Old Web
English
Sign In
Acemap
>
authorDetail
>
Inaha Okuda
Inaha Okuda
GlaxoSmithKline
Albiglutide
Internal medicine
Medicine
Placebo
Hypoglycemia
3
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Weekly glucagon‐like peptide‐1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled study
2018
Journal of Diabetes Investigation
Antonio Nino
Inaha Okuda
Timothy Wilson
Lynn Yue
Hiromu Nakajima
Maho Tsuboi
Molly C. Carr
Yutaka Seino
Show All
Source
Cite
Save
Citations (1)
Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs
2017
Current Medical Research and Opinion
Inaha Okuda
Timothy H. Wilson
Lin Yue
Hiromu Nakajima
Molly C. Carr
Maho Tsuboi
Antonio Nino
Yutaka Seino
Show All
Source
Cite
Save
Citations (4)
A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus
2014
Current Medical Research and Opinion
Yutaka Seino
Nobuya Inagaki
Hajime Miyahara
Inaha Okuda
Mark A. Bush
June Ye
M. Claire Holland
Susan L. Johnson
Eric Lewis
Hiromu Nakajima
Show All
Source
Cite
Save
Citations (25)
1